Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HeartLogic Optimization of CHF Medications in Chronic Low EF Population: A Follow-on Study

NCT07412626 is registered in ClinicalTrials.gov with Robert Pickett as lead sponsor.

NCT NCT07412626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07412626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HeartLogic Optimization of CHF Medications in Chronic Low EF Population: A Follow-on Study
Lead sponsor
Robert Pickett
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
March 31, 2028
Enrollment
135 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure chronic, low ejection fraction